TG THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$20M
Free Cash Flow↑+93400.0% +$20M
$20M
Investing Cash Flow
$46M
Financing Cash Flow
$1M
Capex↑+219.0% +$46K
$67K
Stock Buybacks↓-100.0% -$7M
$0
Stock-Based Comp↑+31.0% +$4M
$16M
Debt Issued
$0
Debt Repaid
—
D&A↑+133.3% +$12K
$21K
SBC Allocated Expense↑+186.6% +$22M
$34M
SBC Unrecognized Cost
—